All articles tagged with #pulsed field ablation
Carolyn Burk, a 75-year-old from Watson, IL, became Illinois’ first patient to receive Abbott’s Volt Pulsed Field Ablation system for atrial fibrillation. The procedure uses rapid electrical pulses to target and destroy faulty heart tissue and can be performed with sedation instead of general anesthesia, performed by Dr. Bharath Rajagopalan at Prairie Cardiovascular.
Nebraska Medicine has introduced a new heart procedure called pulsed-field ablation to treat atrial fibrillation (AFib), a condition where the heart beats irregularly. This procedure, approved by the FDA in December 2023, uses a hydrating electrical field to denature the tissue and make it electrically inactive, without the risks associated with thermal energy. Dr. Jason Payne, a cardiologist at Nebraska Medicine, highlights the safety and efficiency of this procedure, which allows patients to be discharged within a few hours and experience a quick return to normalcy. With the rising number of Nebraskans being diagnosed with AFib, the hospital aims to meet the demand for this procedure in a faster and safer manner.
A newly approved procedure called pulsed field ablation (PFA) is offering hope to patients with atrial fibrillation, a rapidly growing heart disorder in the U.S. Unlike the traditional method of cardiac ablation, PFA uses a non-thermal, high amplitude electrical field to quickly and effectively treat faulty heart tissue in just minutes, with minimal collateral damage. This groundbreaking procedure, recently approved by the FDA, provides a promising alternative for patients who were not candidates for cardiac ablation, potentially improving their quality of life and reducing recovery time.
UCHealth becomes one of the first hospitals in the nation to offer pulsed field ablation, a non-thermal treatment for atrial fibrillation (A-fib), with a Frederick man being the first patient to undergo the procedure. A-fib, an abnormal heartbeat, affects millions of Americans and is a leading cause of stroke. The new method uses electric pulses to isolate pulmonary veins, aiming to reduce collateral damage compared to traditional thermal ablation procedures. Patients report feeling better mere days after the procedure, and the FDA has approved two pulsed field ablation systems, with UCHealth using the Medtronic PulseSelect system.
Boston Scientific is expected to receive FDA approval for its pulsed field ablation method of treating abnormal heartbeats, which uses electrical pulses to selectively kill problematic cardiac cells. In a comparison with thermal ablation, the newer approach showed similar efficacy and safety profiles. The company's stock surged 6% on the news. Analysts believe that this development positions Boston Scientific to capture a significant share of the nearly $8 billion electrophysiology market.